Andersen MH - Search Results

1

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes.

Donia M, Ellebaek E, Andersen MH, Straten PT, Svane IM. Donia M, et al. Among authors: andersen mh. Oncoimmunology. 2012 Nov 1;1(8):1297-1304. doi: 10.4161/onci.21659. Oncoimmunology. 2012. PMID: 23243593 Free PMC article.

2

Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients.

Andersen MH, Pedersen LO, Becker JC, Straten PT. Andersen MH, et al. Cancer Res. 2001 Feb 1;61(3):869-72. Cancer Res. 2001. PMID: 11221872

3

Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progression.

Andersen MH, Keikavoussi P, Bröcker EB, Schuler-Thurner B, Jonassen M, Søndergaard I, Straten PT, Becker JC, Kämpgen E. Andersen MH, et al. Int J Cancer. 2001 Dec 15;94(6):820-4. doi: 10.1002/ijc.1536. Int J Cancer. 2001. PMID: 11745484

4

HLA-B35-restricted immune responses against survivin in cancer patients.

Reker S, Becker JC, Svane IM, Ralfkiaer E, Straten PT, Andersen MH. Reker S, et al. Among authors: andersen mh. Int J Cancer. 2004 Mar 1;108(6):937-41. doi: 10.1002/ijc.11634. Int J Cancer. 2004. PMID: 14712500

5

Identification of novel survivin-derived CTL epitopes.

Reker S, Meier A, Holten-Andersen L, Svane IM, Becker JC, thor Straten P, Andersen MH. Reker S, et al. Among authors: andersen mh. Cancer Biol Ther. 2004 Feb;3(2):173-9. doi: 10.4161/cbt.3.2.611. Epub 2004 Feb 1. Cancer Biol Ther. 2004. PMID: 14726703 Free article.

6

Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAP.

Andersen MH, Becker JC, Straten Pt. Andersen MH, et al. J Invest Dermatol. 2004 May;122(5):1336-7. doi: 10.1111/j.0022-202X.2004.22508.x. J Invest Dermatol. 2004. PMID: 15140242 Free article. No abstract available.

7

Immunogenicity of constitutively active V599EBRaf.

Andersen MH, Fensterle J, Ugurel S, Reker S, Houben R, Guldberg P, Berger TG, Schadendorf D, Trefzer U, Bröcker EB, Straten Pt, Rapp UR, Becker JC. Andersen MH, et al. Cancer Res. 2004 Aug 1;64(15):5456-60. doi: 10.1158/0008-5472.CAN-04-0937. Cancer Res. 2004. PMID: 15289355

8

Immunogenicity of Bcl-2 in patients with cancer.

Andersen MH, Svane IM, Kvistborg P, Nielsen OJ, Balslev E, Reker S, Becker JC, Straten PT. Andersen MH, et al. Blood. 2005 Jan 15;105(2):728-34. doi: 10.1182/blood-2004-07-2548. Epub 2004 Sep 14. Blood. 2005. PMID: 15367432 Free article.

9

Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopes.

Eggert AO, Andersen MH, Voigt H, Schrama D, Kämpgen E, Straten PT, Becker JC. Eggert AO, et al. Among authors: andersen mh. Eur J Immunol. 2004 Nov;34(11):3285-90. doi: 10.1002/eji.200324618. Eur J Immunol. 2004. PMID: 15384049 Free article.

10

Spontaneous T-cell responses against peptides derived from the Taxol resistance-associated gene-3 (TRAG-3) protein in cancer patients.

Meier A, Reker S, Svane IM, Holten-Andersen L, Becker JC, Søndergaard I, Andersen MH, Thor Straten P. Meier A, et al. Among authors: andersen mh. Cancer Immunol Immunother. 2005 Mar;54(3):219-28. doi: 10.1007/s00262-004-0578-9. Epub 2004 Oct 2. Cancer Immunol Immunother. 2005. PMID: 15580499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters